CXCR4 and cancer: Thus, modulators of the tumor environment, such as small kinase inhibitors, antibodies or RNAi, that modulate the suppressive immune environment (i.e., siRNA against STAT3, small molecules against CXCR4, tyrosine kinase inhibitor against vascular endothelial growth factor) are very useful additions to the cancer vaccine complex [14].